Oliver Baumann

Amministratore Delegato presso XLIFE SCIENCES AG

38 anni

Finance

Commercial Services

Health Technology

Profilo

Oliver R.
Baumann is Chief Executive Officer & Director at Xlife Sciences AG since 2020, Chief Executive Officer at Akira Trading GmbH, Chairman at Akira Holding AG, Chairman & General Manager at Veraxa Biotech Holding AG, Director at Pecunia Solutions AG, Director at VERAXA Biotech AG, Director at Axenoll Life Sciences AG, and Co-Managing Director at Xrna.
Biotech GmbH.
Former roles include Chief Executive Officer at Belvoir Wealth Management AG and Co-Managing Director at x-diagnostics GmbH.

Posizioni attive di Oliver Baumann

Società	Posizione	Inizio
XLIFE SCIENCES AG	Amministratore Delegato	01/07/2019
Pecunia Solutions AG	Direttore/Membro del Consiglio	-
Axenoll Life Sciences AG	Direttore/Membro del Consiglio	-
Akira Holding AG	Presidente	-

Tutte le posizioni attive di Oliver Baumann

Precedenti posizioni note di Oliver Baumann

Società	Posizione	Fine
Veraxa Biotech AG Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics	Direttore/Membro del Consiglio	-
Belvoir Wealth Management AG Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Oliver Baumann

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Oliver Baumann

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	6
Belvoir Wealth Management AG Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice	Finance
Pecunia Solutions AG
Xlife Sciences AG Xlife Sciences AG Miscellaneous Commercial ServicesCommercial Services Develops life sciences technologies	Commercial Services
Akira Holding AG
Veraxa Biotech AG Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics	Health Technology
Axenoll Life Sciences AG